Malaria control is a work in progress. Various organizations conduct research and development (R&D) for new insecticides, new drugs and an effective vaccine. In addition to existing malaria control Commodity Manufacturers, these include but are not limited to:Innovative Vector Control Consortium (IVCC)
Medicines for Malaria Venture (MMV)
Malaria Vaccine Initiative (MVI)
Multilateral Initiative on Malaria (MIM)
Global funding for malaria control R&D was approximately $323 million in 2004. This figure has likely increased considerably with contributions from the Gates Foundation. The development of new malaria control tools must be carefully balanced with efforts to save lives with effective tools available today, like Long-Lasting Insecticidal Nets and Artemisinin-based Combination Therapy. Research must also go hand-in-hand with better policies to ensure both existing and new tools reach the poorest and most vulnerable to malaria.
April 05, 2024
Environmentalists Try to Squash a Bug KillerMarch 05, 2024
Disabled protein shortens malaria life cycleFebruary 27, 2024
AFM update on recent drug quality studiesAugust 16, 2023
Medicine that is more placebo than cureJuly 12, 2023
moreJanuary 18, 2024
Mutant mosquitos with glowing red eyes offer eco-friendly malaria controlDecember 08, 2023
Malaria kills a half-million Africans a year. Gene-edited mosquitoes might stop itDecember 07, 2023
One malaria, two malaria: implications of multiple infections on mosquito vectorsDecember 04, 2023
Tanzania: New Six-Pill Malaria Dose Approved By TFDANovember 22, 2023
moreNovember 20, 2023
EMA approves first ever malaria vaccineSeptember 01, 2023
A systematic, realist review of zooprophylaxis for malaria controlAugust 12, 2023
An operational comparative study of quinine and artesunate for the treatment of severe malaria in hospitals and health centres in the Democratic RepubMay 30, 2023
Video studies of passage by Anopheles gambiae mosquitoes through holes in a simulated bed net: effects of hole size, hole orientation and net environmMay 13, 2023
moreMay 23, 2023
Unfounded pesticide concerns adversely affect the health of low-income populationsAugust 30, 2023
Uganda: First vaccination for GMZ2 malaria vaccine trialMay 09, 2023
Bayer CropScience signs research agreement with IVCCMay 14, 2023
DNDi Partners With Pharma, Biotech, Academia, Public Health Institutes & NGOs to Deliver Lifesaving DrugsJune 24, 2023
moreJune 18, 2023
ASTMH Annual MeetingNovember 04, 2023
Fifth AMANET Biennial ConferenceFebruary 26, 2024
more